Want to join the conversation?
Doug Mitchelson of UBS asks about the outlook for mid single-digit domestic affiliate fee revenue growth in FY17. $VIAB said it had benefits from distribution consolidation over the course of FY16. It has good avg. rate increases across its portfolio. There are some benefits and opportunities in distribution. This will lead to affiliate growth.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?